Inhibitor of platelet aggregation
US5294543A · kind A · utility
0Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 1992 |
| Grant date | Mar 15, 1994 |
| Priority date | — |
| Expiry date | Apr 8, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Purified DNA comprising a sequence encoding chrysoptin. Chrysoptin can be used to alter the hemodynamic or hemostatic properties of an animal's blood by administering to the animal an effective amount of chrysoptin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.